Providence Wealth Advisors, LLC Biogen Inc. Transaction History

Providence Wealth Advisors, LLC

  • $134 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$282.99 - $369.05 $169,794 - $221,430
-600 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$259.0 - $414.71 $155,400 - $248,826
600 New
600 $208,000
Q4 2018

Feb 04, 2019
SELL
$278.5 - $352.75 $174,062 - $220,468
-625 Closed
0 $0
Q3 2018

Nov 01, 2018
BUY
$293.51 - $383.83 $183,443 - $239,893
625 New
625 $221,000

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Providence Wealth Advisors, LLC Portfolio

Follow Providence Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Wealth Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email